298 related articles for article (PubMed ID: 8791136)
1. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
Seiden M; Sklar JL
Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
[No Abstract] [Full Text] [Related]
2. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
[TBL] [Abstract][Full Text] [Related]
6. CK20 gene expression: technical limits for the detection of circulating tumor cells.
Champelovier P; Mongelard F; Seigneurin D
Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
[TBL] [Abstract][Full Text] [Related]
7. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor cells in bladder cancer patients.
Nezos A; Pissimisis N; Lembessis P; Sourla A; Dimopoulos P; Dimopoulos T; Tzelepis K; Koutsilieris M
Cancer Treat Rev; 2009 May; 35(3):272-9. PubMed ID: 19103472
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma.
Burchill SA; Kinsey SE; Picton S; Roberts P; Pinkerton CR; Selby P; Lewis IJ
Med Pediatr Oncol; 2001 Jan; 36(1):213-9. PubMed ID: 11464888
[TBL] [Abstract][Full Text] [Related]
10. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Cheung IY; Cheung NK
Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
[TBL] [Abstract][Full Text] [Related]
11. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
[TBL] [Abstract][Full Text] [Related]
12. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
13. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
14. [Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours].
Schleiermacher G; Delattre O
Bull Cancer; 2001 Jun; 88(6):561-70. PubMed ID: 11459702
[TBL] [Abstract][Full Text] [Related]
15. PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: effect of enzyme and sampling.
Lin JC; Chen KY; Wang WY; Jan JS; Wei YH
Head Neck; 2002 Jun; 24(6):591-6. PubMed ID: 12112557
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
Fellowes VS; Husebekk A; Gress RE; Vance BA
Int J Oncol; 2004 Apr; 24(4):861-7. PubMed ID: 15010823
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of gene mutations and methylation abnormalities: applications in solid tumor diagnosis.
Kraus A; Schuermann M
Expert Rev Mol Diagn; 2002 Mar; 2(2):97-108. PubMed ID: 11962346
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostic detection of circulating tumor cells and their prognostic implications].
Nakanishi H; Tatematsu M
Gan To Kagaku Ryoho; 1997 Feb; 24(3):257-65. PubMed ID: 9051125
[TBL] [Abstract][Full Text] [Related]
19. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
20. New molecular diagnostic methods in head and neck cancer.
Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]